Twist Bioscience

$137.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$3.20 (+2.38%) Today

+$0.17 (+0.12%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell TWST and other stocks, options, and ETFs commission-free!

About TWST

Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The firm also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. The company was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013 and is headquartered in San Francisco, CA. The listed name for TWST is Twist Bioscience Corporation Common Stock.

CEO

Emily Marine Leproust

Employees

525

Headquarters

San Francisco, California

Founded

2013

Market Cap

6.74B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.03M

High Today

$140.47

Low Today

$125.99

Open Price

$134.71

Volume

883.24K

52 Week High

$214.07

52 Week Low

$18.52

TWST News

BenzingaFeb 24

Twist Bioscience Launches Methylation Detection Systems

Twist Bioscience Corp (NASDAQ: TWST) has launched its NGS Methylation Detection System, end-to-end sample preparation, and target enrichment solution for identi

TWST Earnings

-$1.00

-$0.67

-$0.33

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected May 6, After Hours